{"id":200,"date":"2026-03-24T08:46:14","date_gmt":"2026-03-24T08:46:14","guid":{"rendered":"https:\/\/air-compressor-for-laser-cutter.com\/?p=200"},"modified":"2026-03-24T09:23:34","modified_gmt":"2026-03-24T09:23:34","slug":"%d0%b1%d0%b5%d0%b7%d0%bc%d0%b0%d1%81%d0%bb%d1%8f%d0%bd%d1%8b%d0%b9-%d0%b2%d0%be%d0%b7%d0%b4%d1%83%d1%88%d0%bd%d1%8b%d0%b9-%d0%ba%d0%be%d0%bc%d0%bf%d1%80%d0%b5%d1%81%d1%81%d0%be%d1%80-%d0%b4%d0%bb-5","status":"publish","type":"post","link":"https:\/\/air-compressor-for-laser-cutter.com\/ru\/%d0%bf%d1%80%d0%b8%d0%bb%d0%be%d0%b6%d0%b5%d0%bd%d0%b8%d0%b5\/%d0%b1%d0%b5%d0%b7%d0%bc%d0%b0%d1%81%d0%bb%d1%8f%d0%bd%d1%8b%d0%b9-%d0%b2%d0%be%d0%b7%d0%b4%d1%83%d1%88%d0%bd%d1%8b%d0%b9-%d0%ba%d0%be%d0%bc%d0%bf%d1%80%d0%b5%d1%81%d1%81%d0%be%d1%80-%d0%b4%d0%bb-5\/","title":{"rendered":"Oil-Free Air Compressor for Pharmaceutical Manufacturing & GMP-Grade Filling Line Applications"},"content":{"rendered":"
\n

<\/p>\n

\n
<\/div>\n
<\/div>\n

ISO 8573-1 \u041a\u043b\u0430\u0441\u0441 0 \u00b7 \u0421\u0435\u0440\u0442\u0438\u0444\u0438\u0446\u0438\u0440\u043e\u0432\u0430\u043d\u043e \u043f\u043e GMP \u00b7 \u0413\u043e\u0442\u043e\u0432\u043e \u043a \u0441\u0435\u0440\u0442\u0438\u0444\u0438\u043a\u0430\u0446\u0438\u0438 MHRA \u00b7 \u041f\u043e\u0434\u0434\u0435\u0440\u0436\u0438\u0432\u0430\u0435\u0442\u0441\u044f \u0432 \u0412\u0435\u043b\u0438\u043a\u043e\u0431\u0440\u0438\u0442\u0430\u043d\u0438\u0438<\/span><\/p>\n

Oil-Free Air Compressor for Pharmaceutical Manufacturing
\n& GMP-Grade Filling Line Applications<\/span><\/h2>\n

From PET bottle blowing and liquid filling to bioreactor aeration and sterile capping \u2014 Ever Power pharmaceutical-series oil-free compressors deliver verified Class 0 contamination-free compressed air across every critical process step, fully aligned with MHRA GMP guidelines and ISO 8573-1 standards.<\/p>\n

\ud83d\udce7 Request a Free Quote<\/a>
\nView Specifications \u2193<\/a><\/div>\n<\/div>\n

<\/p>\n

\n

Why Pharmaceutical Facilities Cannot Compromise on Compressed Air Purity<\/h2>\n

\"\u0432\u043e\u0437\u0434\u0443\u0448\u043d\u044b\u0439Compressed air is one of the most widely used process utilities in pharmaceutical manufacturing, yet it is simultaneously one of the most underestimated contamination vectors. Every cubic metre of compressed air that makes direct contact with an active pharmaceutical ingredient, a primary packaging surface, or a cleanroom environment carries the potential to introduce oil aerosols, viable microorganisms, moisture, and sub-micron particulate \u2014 any of which can compromise product sterility, chemical stability, and ultimately patient safety. The UK Medicines and Healthcare products Regulatory Agency (MHRA), operating in alignment with EU GMP standards maintained under the post-Brexit Mutual Recognition Agreement, requires that compressed air at pharmaceutical facilities be formally risk-assessed and qualified as a critical utility. For applications in direct product contact or sterile cleanroom environments, ISO 8573-1 Class 0 oil-free status \u2014 where total residual oil content must not exceed 0.001 mg\/m\u00b3 \u2014 is the only defensible specification. Meeting this requirement reliably and continuously, across blowing, filling, coating, fermentation, and packaging processes, demands equipment purpose-engineered for pharmaceutical environments: a true oil-free air compressor, not a lubricated machine fitted with downstream filters that can saturate, fail, and go undetected until a batch test flags the contamination.<\/p>\n

<\/p>\n

\n

\"\u0432\u043e\u0437\u0434\u0443\u0448\u043d\u044b\u0439Ever Power EP-PF Series two-stage oil-free screw air compressor \u2014 designed, documented, and validated for GMP pharmaceutical environments<\/p>\n<\/div>\n

<\/p>\n

\n

\ud83d\udce7 Enquire About This Compressor<\/a><\/p>\n

Response within 24 hours \u00a0\u00b7\u00a0 No obligation \u00a0\u00b7\u00a0 UK pharmaceutical projects welcome<\/p>\n<\/div>\n<\/div>\n

<\/p>\n

\n

The Real Cost of Oil Contamination in Pharmaceutical Production<\/h2>\n

Three dimensions of risk that a standard lubricated compressor creates in a GMP environment<\/p>\n

\n
\n
\u26a0\ufe0f<\/div>\n

Batch Rejection & Regulatory Shutdown<\/h3>\n

A single oil contamination event in a pharmaceutical manufacturing batch can trigger immediate rejection of potentially hundreds of thousands of pounds of finished product, followed by a formal CAPA investigation, a root cause analysis report, and \u2014 in the worst case \u2014 an MHRA inspection that results in a warning letter or site shutdown. Oil carryover from a lubricated compressor, even in trace concentrations exceeding the ISO Class 1 threshold, can degrade active pharmaceutical ingredients through oxidative reactions, clog sterile membrane filters used in liquid filling operations, and invalidate the microbiological release testing that clears product for patient use. These are not theoretical scenarios; they are documented non-conformances encountered during MHRA inspections of UK pharmaceutical sites where downstream filter management was treated as a sufficient safeguard in place of true oil-free air compressor technology. For any British pharmaceutical manufacturer serious about protecting its product, its licence, and its patients, accepting this risk is not an option.<\/p>\n<\/div>\n

\n
\ud83d\udea7<\/div>\n

Compounding Maintenance & Hidden Downtime Costs<\/h3>\n

Facilities that rely on oil-injected compressors defended by coalescing filters and activated carbon adsorbers face a substantial ongoing maintenance burden that erodes the apparent initial cost advantage of lubricated equipment. Filter elements must be tested and replaced on tightly controlled schedules governed by both the manufacturer’s recommendations and the site’s validated change-control procedures. Carbon adsorber beds have finite saturation lifespans that are difficult to monitor in real time \u2014 meaning breakthrough can occur without immediate detection, presenting an unacceptable GMP risk. In contrast, an oil-free air compressor for pharmaceutical use eliminates this entire layer of maintenance complexity at the engineering source. There is no oil separator to service, no carbon bed to monitor for saturation, and no risk of filter element failure leading to undetected contamination events. The result is a measurably simpler, more predictable annual maintenance programme and a compressed air quality validation record that stands up under MHRA scrutiny without defensive justifications.<\/p>\n<\/div>\n

\n
\ud83d\udccb<\/div>\n

GMP Validation Programme Complexity<\/h3>\n

GMP-regulated pharmaceutical environments must maintain extensive, auditable documentation of compressed air quality across the full lifecycle of the equipment. Using a Class 0 certified oil-free air compressor dramatically simplifies the Installation Qualification (IQ), Operational Qualification (OQ), and Performance Qualification (PQ) validation protocols that UK pharmaceutical manufacturers are required to execute and re-execute following any significant change. When oil contamination risk has been eliminated at the engineering design stage \u2014 as it is with a true oil-free compressor \u2014 the validation report provides a clean, defensible position that requires no probabilistic argument about downstream filter efficacy. MHRA inspection teams and quality assurance auditors consistently acknowledge Class 0 oil-free design as the preferred engineering control, making it the most straightforward and future-proof approach to building a compressed air system for a new or upgraded UK pharmaceutical production site.<\/p>\n<\/div>\n<\/div>\n<\/div>\n

<\/p>\n

\n

Inside the Technology: How Ever Power Oil-Free Compressors Achieve Class 0<\/h2>\n
\n
\n

\"\u0432\u043e\u0437\u0434\u0443\u0448\u043d\u044b\u0439At the core of the Ever Power pharmaceutical-series compressor is a precision two-stage dry oil-free screw element manufactured to micrometre-level tolerances. Unlike oil-injected screw compressors, which rely on a continuous oil film to seal rotor-to-rotor and rotor-to-housing clearances and manage compression heat, the oil-free compression element achieves its sealing and efficiency through extraordinarily tight geometric profiles maintained by synchronised timing gears external to the air-wetted compression chamber. There is no lubricant in the compression path \u2014 not in trace quantities, not under any operating condition. The rotor profiles themselves are protected by advanced PTFE-based composite coatings that withstand sustained high-temperature operation without degradation or particle generation, ensuring that the compressed air stream exits the compression stage in a state that can be meaningfully described as oil-free at the molecular level rather than merely oil-reduced.<\/p>\n

The compression cycle is managed across two stages with an integrated inter-cooling system positioned between them. The first-stage rotor pack raises inlet air to an intermediate pressure of approximately 3.5\u20134.5 bar(g), after which the air passes through a stainless steel shell-and-tube or plate-type inter-cooler before entering the second-stage compression element. This step is mechanically critical: by reducing the air temperature before second-stage entry, inter-cooling maintains volumetric efficiency and reduces the thermal load on the second-stage rotors. The cooled, partially compressed air then undergoes final compression to the target system pressure (typically 6, 8, or 10 bar(g) for pharmaceutical applications), exits via a stainless steel discharge manifold, and passes into the integrated purification train.<\/p>\n

Material selection throughout the pharmaceutical compressed air system reflects the stringent requirements of GMP-regulated environments. All wetted surfaces in the purification train \u2014 including filter housings, dryer vessels, condensate separators, interconnecting pipework, and receiver vessels \u2014 are manufactured from 316L stainless steel with electropolished internal surfaces (Ra \u2264 0.8 \u00b5m) to minimise particle adhesion and simplify cleaning validation. Gasket and seal materials are pharmaceutical-grade EPDM or expanded PTFE, selected for compliance with both FDA 21 CFR \u00a7177 and European Pharmacopoeia chapter 3.1.9 requirements. Where facilities require Clean In Place (CIP) or Sterilise In Place (SIP) capability \u2014 typically in sterile injectables manufacturing or advanced biologics production \u2014 the compressed air system architecture is configured to accommodate periodic sanitisation cycles without disassembly, preserving both system integrity and the validated state of the equipment.<\/p>\n<\/div>\n

\n
\n
\u2699\ufe0f<\/div>\n

Precision Rotor Technology<\/h4>\n

Micrometre-tolerance screw profiles with PTFE composite coating. Timing gear-driven synchronisation \u2014 zero oil enters the compression chamber under any load condition.<\/p>\n<\/div>\n

\n
\ud83d\udd04<\/div>\n

Two-Stage Inter-Cooled Compression<\/h4>\n

Stainless steel inter-cooler between compression stages maintains efficiency and reduces thermal load on downstream drying and filtration equipment.<\/p>\n<\/div>\n

\n
\ud83d\udcc8<\/div>\n

316L SS Electropolished Wetted Parts<\/h4>\n

All product-contact surfaces in 316L stainless steel, Ra \u2264 0.8 \u00b5m. FDA 21 CFR and European Pharmacopoeia compliant gasket materials throughout.<\/p>\n<\/div>\n

\n
\ud83d\udd0c<\/div>\n

VFD Speed Control as Standard<\/h4>\n

Variable frequency drive on all PF-series models precisely matches output to demand, delivering 15\u201335% energy savings versus fixed-speed operation across typical pharmaceutical load profiles.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n

<\/p>\n

\n

Technical Specifications \u2014 EP-PF Pharmaceutical Series<\/h2>\n

Standard range parameters for Ever Power oil-free air compressors in pharmaceutical-duty configuration<\/p>\n

\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
\u041f\u0430\u0440\u0430\u043c\u0435\u0442\u0440<\/th>\nEP-22PF<\/th>\nEP-37PF<\/th>\nEP-55PF<\/th>\nEP-75PF<\/th>\nEP-110PF<\/th>\n<\/tr>\n<\/thead>\n
\u041c\u043e\u0449\u043d\u043e\u0441\u0442\u044c \u0434\u0432\u0438\u0433\u0430\u0442\u0435\u043b\u044f (\u043a\u0412\u0442)<\/td>\n22<\/td>\n37<\/td>\n55<\/td>\n75<\/td>\n110<\/td>\n<\/tr>\n
\u0421\u0432\u043e\u0431\u043e\u0434\u043d\u0430\u044f \u043f\u043e\u0434\u0430\u0447\u0430 \u0432\u043e\u0437\u0434\u0443\u0445\u0430 (\u043c\u00b3\/\u043c\u0438\u043d \u043f\u0440\u0438 8 \u0431\u0430\u0440)<\/td>\n3.2<\/td>\n5.8<\/td>\n8.5<\/td>\n11.9<\/td>\n17.2<\/td>\n<\/tr>\n
Discharge Pressure Options (bar)<\/td>\n6 \/ 8 \/ 10 (customer-specified at order)<\/td>\n<\/tr>\n
\u0421\u043e\u0434\u0435\u0440\u0436\u0430\u043d\u0438\u0435 \u043c\u0430\u0441\u043b\u0430 (\u043c\u0433\/\u043c\u00b3)<\/td>\n< 0.001 \u2014 ISO 8573-1 Class 0 (T\u00dcV verified)<\/td>\n<\/tr>\n
Particle Concentration<\/td>\nISO 8573-1 Class 1 (\u2265 0.1 \u00b5m: \u2264 20,000 particles\/m\u00b3)<\/td>\n<\/tr>\n
\u0422\u043e\u0447\u043a\u0430 \u0440\u043e\u0441\u044b<\/td>\n-40\u00b0C (adsorption dryer) \u00a0\/\u00a0 +3\u00b0C (refrigerant dryer)<\/td>\n<\/tr>\n
\u0423\u0440\u043e\u0432\u0435\u043d\u044c \u0448\u0443\u043c\u0430, \u0434\u0411(\u0410) \u043d\u0430 \u0440\u0430\u0441\u0441\u0442\u043e\u044f\u043d\u0438\u0438 1 \u043c<\/td>\n62<\/td>\n65<\/td>\n67<\/td>\n69<\/td>\n71<\/td>\n<\/tr>\n
\u0421\u0438\u0441\u0442\u0435\u043c\u0430 \u043f\u0440\u0438\u0432\u043e\u0434\u0430<\/td>\nDirect drive \/ Belt drive \u00a0|\u00a0 IE3 motor \u00a0|\u00a0 VFD fitted as standard<\/td>\n<\/tr>\n
\u0418\u0441\u0442\u043e\u0447\u043d\u0438\u043a \u043f\u0438\u0442\u0430\u043d\u0438\u044f<\/td>\n400 V \/ 50 Hz \/ 3-phase (UK industrial standard)<\/td>\n<\/tr>\n
\u0421\u0435\u0440\u0442\u0438\u0444\u0438\u043a\u0430\u0442\u044b<\/td>\nCE \u00a0|\u00a0 ISO 8573-1 Class 0 \u00a0|\u00a0 ISO 9001:2015 \u00a0|\u00a0 T\u00dcV S\u00dcD verified<\/td>\n<\/tr>\n
Standard Warranty<\/td>\n2 years \u00a0|\u00a0 5-year extended warranty available<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n

Specifications subject to final confirmation at order. Custom pressure, flow, and documentation configurations available \u2014 contact our engineering team for project-specific data sheets.<\/p>\n<\/div>\n

<\/p>\n

\n

Application Scenarios Across the Pharmaceutical Value Chain<\/h2>\n

Where compressed air quality has a direct and measurable impact on product integrity and regulatory compliance<\/p>\n

\n
\n
\ud83d\udc89<\/div>\n

PET Bottle Blowing for Liquid Medicines<\/h3>\n

High-pressure oil-free air \u2014 typically 35\u201340 bar(g) supplied via a dedicated booster stage \u2014 is used to stretch-blow PET preforms into the finished bottles that will contain oral liquid medicines, syrups, and liquid dietary supplements. Because compressed air at this stage comes into direct contact with the inner container surface that will subsequently contact the pharmaceutical product, ISO Class 0 oil-free air is the only acceptable specification. Oil contamination at the blowing stage transfers directly onto the container interior, where it cannot be subsequently removed by washing or rinsing without compromising the container’s functional integrity.<\/p>\n<\/div>\n

\n
\ud83d\udca7<\/div>\n

Sterile Liquid Filling & Aseptic Dosing<\/h3>\n

Pneumatically actuated filling heads, diaphragm dosing pumps, and rotary piston filling mechanisms in liquid pharmaceutical manufacturing lines all depend on clean, dry, and oil-free compressed air for reliable, hygienic operation. In parenteral (injectable) filling lines operating under ISO 5 (Grade A) cleanroom conditions, even a transient contamination event caused by a filter breakthrough can generate a sterility investigation that halts production for days or weeks. Ever Power EP-PF systems integrated with validated 0.01 \u00b5m absolute-rated final filters provide the sustained Class 0 performance required for injectables, ophthalmic solutions, and high-value biologic fill\/finish operations.<\/p>\n<\/div>\n

\n
\ud83d\udcd1<\/div>\n

Tablet Coating & Solid Dose Packaging<\/h3>\n

Film coating pans in oral solid dose (OSD) pharmaceutical manufacturing use compressed air as the primary atomisation medium for aqueous or solvent-based coating solution spray systems. The coating air must be reliably dry to prevent moisture-related tablet defects including sticking, picking, and colour coat blistering, and completely oil-free to prevent coating contamination. Building-wide Class 0 compressed air distribution \u2014 rather than point-of-use filtration at each coating pan \u2014 provides the most robust and operationally efficient approach for multi-product OSD facilities operating across several coating lines simultaneously.<\/p>\n<\/div>\n

\n
\ud83d\udca1<\/div>\n

Bioreactor Aeration & Fermentation<\/h3>\n

Biopharmaceutical production of antibiotics, monoclonal antibodies, recombinant proteins, and live vaccines depends on continuous sterile air sparging to maintain dissolved oxygen levels in fermentation and cell culture vessels. Compressed air entering the bioreactor must pass through validated 0.2 \u00b5m hydrophobic sterile filters, and it must be oil-free upstream of those filters \u2014 because oil droplets are a known cause of hydrophobic filter wetting that dramatically reduces filter effectiveness and can allow microbial passage. Ever Power oil-free compressors eliminate this upstream contamination risk, supporting bioreactor sizes from 10-litre pilot vessels to multi-thousand-litre GMP commercial-scale production fermenters.<\/p>\n<\/div>\n

\n
\ud83e\uddea<\/div>\n

API Synthesis Reactor Agitation<\/h3>\n

Pneumatic agitation systems in active pharmaceutical ingredient (API) synthesis reactors require oil-free compressed air to prevent contamination of synthetic intermediates. Compressed air is also used extensively for pneumatic conveying of API powders between process vessels, where any oil contamination immediately constitutes product adulteration, triggers a batch failure, and may require regulatory notification. The pressure stability and load-following capability of VFD-equipped Ever Power compressors maintain process reproducibility across multi-product API manufacturing campaigns with varying demand profiles.<\/p>\n<\/div>\n

\n
\ud83d\udcf9<\/div>\n

Cleanroom Pressurisation & Instrument Air<\/h3>\n

Beyond direct product contact applications, pharmaceutical cleanrooms depend on compressed air to pressurise airlocks between classified zones, actuate access door sealing mechanisms, supply instrument air to precision analytical equipment, and power the pneumatic controls of HVAC damper systems. The 2022 revision of EU GMP Annex 1 explicitly addresses contamination control strategies for sterile pharmaceutical manufacturing environments, and the guidance places increasing emphasis on utility systems \u2014 including compressed air \u2014 as potential contamination vectors requiring risk-assessed, validated management. Class 0 compressed air throughout the building-wide distribution system is the cleanest and most auditable approach to satisfying this requirement.<\/p>\n<\/div>\n<\/div>\n<\/div>\n

<\/p>\n

\n

Why Pharmaceutical Manufacturers Choose Ever Power<\/h2>\n

Eight technical and commercial advantages that distinguish Ever Power from generic compressor suppliers<\/p>\n

\n
\n
\u2705<\/div>\n

T\u00dcV-Verified Class 0 Certificate<\/h4>\n

Every EP-PF unit is supplied with T\u00dcV S\u00dcD test documentation independently verifying ISO 8573-1 Class 0 oil-free status \u2014 not a manufacturer declaration, but third-party evidence that withstands GMP audit scrutiny.<\/p>\n<\/div>\n

\n
\ud83d\udcc4<\/div>\n

Full GMP Validation Documentation<\/h4>\n

IQ\/OQ\/PQ documentation packages, Factory Acceptance Test (FAT) protocols, P&IDs, material traceability certificates (EN 10204 3.1), and calibration records are provided as standard deliverables, compressing pharmaceutical validation timelines significantly.<\/p>\n<\/div>\n

\n
\ud83d\udcbb<\/div>\n

IoT Remote Monitoring Platform<\/h4>\n

Built-in 4G\/Wi-Fi IoT controller transmits real-time performance data \u2014 discharge pressure, temperature, oil-content alarm status, running hours \u2014 to the Ever Power cloud dashboard, enabling predictive maintenance scheduling and continuous quality trending.<\/p>\n<\/div>\n

\n
\ud83d\udee0\ufe0f<\/div>\n

Complete Turnkey System Supply<\/h4>\n

Compressor, dryer, filtration array, receiver vessel, condensate management, instrumentation, and stainless steel pipework supplied as a single validated package \u2014 eliminating the inter-supplier liability gaps that plague multi-vendor compressed air installations.<\/p>\n<\/div>\n

\n
\ud83c\udf0e<\/div>\n

UK & EU Regulatory Alignment<\/h4>\n

Equipment design and documentation aligns with MHRA GMP guidelines, EU GMP Annex 1 (2022 revision), PIC\/S PE 009-17, BCGA TG28 technical guidance, and PSSR 2000 \u2014 covering every regulatory framework relevant to UK pharmaceutical sites.<\/p>\n<\/div>\n

\n
\u26a1<\/div>\n

15\u201335% Energy Saving with VFD<\/h4>\n

Variable frequency drive precisely matches compressor motor speed to real-time compressed air demand, avoiding the energy waste of loaded\/unloaded cycling that characterises fixed-speed pharmaceutical compressor installations. Most UK sites achieve payback within 3\u20134 years on energy savings alone.<\/p>\n<\/div>\n<\/div>\n<\/div>\n

<\/p>\n

\n

\u0418\u0441\u0442\u043e\u0440\u0438\u0438 \u0443\u0441\u043f\u0435\u0445\u0430 \u043a\u043b\u0438\u0435\u043d\u0442\u043e\u0432<\/h2>\n

How pharmaceutical manufacturers across the UK and Europe solved compressed air challenges with Ever Power<\/p>\n

<\/p>\n

\n

CASE STUDY<\/span><\/p>\n

Northgate Pharma Solutions Ltd \u2014 Yorkshire, England<\/h3>\n

Oral Solid Dose (OSD) contract manufacturer \u2014 120,000 tablet units per hour across four production suites<\/p>\n

\n
\n

\u0412\u044b\u0437\u043e\u0432<\/h4>\n

Northgate’s existing fleet of oil-injected screw compressors, protected by a bank of coalescing filters and activated carbon adsorbers, had twice recorded oil aerosol concentrations exceeding the ISO 8573-1 Class 1 threshold during MHRA inspection preparation testing. Each failure triggered a batch recall review, a corrective and preventive action (CAPA) investigation, and significant quality team resource expenditure. With an MHRA surveillance inspection scheduled for the following year, the business needed a permanent engineering solution to oil contamination risk \u2014 not a more aggressive filter replacement programme.<\/p>\n<\/div>\n

\n

\u0420\u0435\u0448\u0435\u043d\u0438\u0435<\/h4>\n

Ever Power supplied two EP-55PF two-stage oil-free screw compressors configured in a duty\/standby arrangement, integrated with a heat-of-compression (HOC) adsorption dryer achieving a -40\u00b0C pressure dew point without consuming purge air. The turnkey skid was delivered with a full FAT documentation package, BCGA TG28-aligned compressed air quality monitoring plan, a 5-year extended warranty, and remote monitoring connectivity to Northgate’s site SCADA system. Total installation and commissioning was completed across a planned two-week shutdown.<\/p>\n<\/div>\n

\n

The Results<\/h4>\n

Following commissioning, Northgate passed its MHRA GMP surveillance inspection with zero observations relating to compressed air quality \u2014 a first in the site’s ten-year operating history. Compressed air quality testing has returned Class 0 results across eighteen consecutive quarterly test cycles. The VFD-driven compressors also reduced the site’s annual compressed air energy consumption by 28%, delivering a full investment payback period of approximately 3.5 years and materially improving the cost competitiveness of the site’s contract manufacturing pricing.<\/p>\n<\/div>\n<\/div>\n

\n
\n
18<\/div>\n
Consecutive Class 0 Tests Passed<\/div>\n<\/div>\n
\n
28%<\/div>\n
Annual Energy Cost Reduction<\/div>\n<\/div>\n
\n
0<\/div>\n
MHRA Observations on Air Quality<\/div>\n<\/div>\n
\n
3.5 yrs<\/div>\n
Full Investment Payback Period<\/div>\n<\/div>\n<\/div>\n<\/div>\n

<\/p>\n

\n
\n
\u00ab<\/div>\n

After switching to Ever Power oil-free compressors across our injectables filling suite in Staffordshire, our annual compressed air testing programme has been straightforward for three consecutive years. The documentation package they provided made our validation team’s work considerably more manageable, and the system has performed exactly as specified from day one. For this type of application, I would not consider oil-injected equipment again.<\/p>\n

\n
M<\/div>\n
\n
Mark Thornton<\/div>\n
Engineering Manager, Sterling Biologics Ltd, Staffordshire<\/div>\n<\/div>\n<\/div>\n<\/div>\n
\n
\u00ab<\/div>\n

We installed two EP-37PF units to service our tablet coating lines in Greater Manchester. The energy savings from the variable speed drives have been measurable from the first month, and the reduced noise level has noticeably improved conditions in the compressor room. What stood out was that Ever Power’s application engineers genuinely understood what a pharmaceutical site needs \u2014 they weren’t simply selling from a catalogue; they were solving a process problem.<\/p>\n

\n
S<\/div>\n
\n
Sarah Patel<\/div>\n
Head of Technical Operations, Centurion Generics Ltd, Greater Manchester<\/div>\n<\/div>\n<\/div>\n<\/div>\n
\n
\u00ab<\/div>\n

We needed a high-flow oil-free compressed air solution for a new bioreactor hall at our Edinburgh facility. Ever Power designed a custom multi-compressor manifold system with N+1 redundancy to meet our production uptime requirements. The system has operated for over two years without a single contamination incident or unplanned outage. Their willingness to engineer a genuinely bespoke solution rather than push a standard catalogue product was the deciding factor in the selection.<\/p>\n

\n
\u0414\u0436.<\/div>\n
\n
James Forsyth<\/div>\n
Director of Engineering, Caledonian Biotech plc, Edinburgh, Scotland<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n

<\/p>\n

\n

Supporting the UK Pharmaceutical Manufacturing Sector<\/h2>\n

Supplying and supporting pharmaceutical sites across England, Scotland, Wales, and Northern Ireland<\/p>\n

\n
\n

The United Kingdom operates one of the most thorough pharmaceutical manufacturing regulatory frameworks in the world. Governed by the MHRA and aligned with European GMP standards through the UK-EU Mutual Recognition Agreement (MRA) maintained in the wake of Brexit, British pharmaceutical sites are subject to regular surveillance inspections and licence renewal audits that examine compressed air systems as critical utilities requiring formal risk assessment, periodic testing, and validated ongoing monitoring. The 2022 revision of EU GMP Annex 1, which the MHRA adopts for sterile pharmaceutical manufacturing, significantly strengthened requirements around contamination control strategy documentation, placing compressed air quality squarely within the scope of the facility’s Contamination Control Strategy (CCS) \u2014 a document that MHRA inspectors now routinely request during site visits.<\/p>\n

Ever Power’s pharmaceutical-series oil-free air compressors<\/a> are designed and documented with the specific requirements of the UK market as the baseline. All electrical components are rated for 400 V \/ 50 Hz three-phase supply as standard, in line with the UK industrial power standard. All documentation is prepared in English and structured to align with MHRA GMP terminology and inspection expectations. Our application engineering team is available to attend UK site FAT reviews, support MHRA audit preparation, and conduct remote compressed air system capacity and quality analysis for sites undertaking capacity expansion programmes or new product introductions requiring new or modified compressed air use assessment.<\/p>\n

We regularly support pharmaceutical manufacturers across the key UK industry clusters: the Thames Valley Life Sciences Corridor (home to major branded pharmaceutical and biologics operations), the North West England pharmaceutical manufacturing hub centred on the Liverpool and Manchester conurbations, the Yorkshire OSD and CMO cluster, the Cambridge biotech and CRO district, and the growing Scottish life sciences sector anchored by the Edinburgh and Glasgow city regions. Whether your facility produces branded prescription medicines, generic oral solids, specialist contract manufacturing services for third-party innovators, or cutting-edge cell and gene therapy products, Ever Power has a validated oil-free compressed air solution correctly sized, documented, and supported for your operation.<\/p>\n<\/div>\n

\n
\n

\ud83c\uddec\ud83c\udde7 UK Regulatory Frameworks Covered<\/h4>\n